stockrowDexCom, Inc. (DXCM) vs Zimmer Biomet Holdings, Inc. (ZBH)
- DexCom, Inc. DXCM 79.50 −5.87%
- Zimmer Biomet Holdings, Inc. ZBH 105.28 −1.47%
DexCom, Inc. and Zimmer Biomet Holdings, Inc. are both Medical Devices companies. DexCom, Inc. is the larger, with a market value of $31.5B against $20.4B — 1.5× the size. Zimmer Biomet Holdings, Inc. trades at the lower P/E: 26.9× against 32.6×. DexCom, Inc. grew revenue faster over the last twelve months: 13.0% against 6.98%. DexCom, Inc. has the higher net margin (19.4% vs 8.95%) and the higher return on invested capital (39.0% vs 3.66%). Across the 22 metrics below, DexCom, Inc. leads on 13 and Zimmer Biomet Holdings, Inc. on 9.
Valuation
Profitability
| Metric | DXCM | ZBH | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.42% | 69.68% | 57.76% |
| Operating margin | 23.98% | 13.55% | (15.07%) |
| Net margin | 19.41% | 8.95% | (14.45%) |
| Free cash flow margin | 21.52% | 13.02% | (3.88%) |
| Return on equity | 37.67% | 6.02% | (10.35%) |
| Return on assets | 14.43% | 3.26% | (17.26%) |
| Return on invested capital | 39.00% | 3.66% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack